The mission of the Center for Translational Medicine is to support the development of novel, investigator-initiated treatment strategies in order to facilitate the implementation of new therapies for patients and achieve new breakthroughs in medicine at the University. The Center has a well-equipped lab and a full-time staff and provides the infrastructure, expertise and resources necessary to translate innovative drugs, biological reagents and devices into Phase 1 clinical trials.  Working with innovators from across the University, the Center designs and conducts the preclinical studies necessary for IND/IDE development and supports Phase I clinical trial design and implementation, including manufacture of clinical product.